| Identification of blood microRNAs associated to Parkinsońs disease R Margis, R Margis, CRM Rieder Journal of biotechnology 152 (3), 96-101, 2011 | 309 | 2011 |
| DNAJC6 Mutations Associated With Early‐Onset Parkinson's Disease S Olgiati, M Quadri, M Fang, JPMA Rood, JA Saute, HF Chien, ... Annals of neurology 79 (2), 244-256, 2016 | 187 | 2016 |
| Iron and oxidative stress in Parkinson’s disease: an observational study of injury biomarkers MS Medeiros, A Schumacher-Schuh, AM Cardoso, GV Bochi, ... PloS one 11 (1), e0146129, 2016 | 153 | 2016 |
| Characterization of cognitive and motor performance during dual-tasking in healthy older adults and patients with Parkinson’s disease LB Wild, DB de Lima, JB Balardin, L Rizzi, BL Giacobbo, HB Oliveira, ... Journal of neurology 260, 580-589, 2013 | 149 | 2013 |
| Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial EP Monteiro, LT Franzoni, DM Cubillos, A de Oliveira Fagundes, ... Scandinavian journal of medicine & science in sports 27 (3), 351-358, 2017 | 137 | 2017 |
| LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study M Quadri, W Mandemakers, MM Grochowska, R Masius, H Geut, ... The Lancet Neurology 17 (7), 597-608, 2018 | 120 | 2018 |
| S100B and NSE serum levels in patients with Parkinson's disease DV Schaf, ABL Tort, D Fricke, P Schestatsky, LVC Portela, DO Souza, ... Parkinsonism & related disorders 11 (1), 39-43, 2005 | 106 | 2005 |
| DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients M Rieck, AF Schumacher-Schuh, V Altmann, CLM Francisconi, ... Pharmacogenomics 13 (15), 1701-1710, 2012 | 98 | 2012 |
| Interleukin-6 serum levels in patients with Parkinson’s disease KW Hofmann, AFS Schuh, J Saute, R Townsend, D Fricke, R Leke, ... Neurochemical research 34, 1401-1404, 2009 | 91 | 2009 |
| Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson´ s disease EF Dos Santos, ENB Busanello, A Miglioranza, Â Zanatta, AG Barchak, ... Metabolic brain disease 24, 257-269, 2009 | 91 | 2009 |
| A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3) C Kieling, CRM Rieder, ACF Silva, JAM Saute, CR Cecchin, TL Monte, ... European journal of neurology 15 (4), 371-376, 2008 | 85 | 2008 |
| A randomized, phase 2 clinical trial of lithium carbonate in Machado‐Joseph disease JAM Saute, RM de Castilhos, TL Monte, AF Schumacher‐Schuh, ... Movement Disorders 29 (4), 568-573, 2014 | 80 | 2014 |
| A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm CRM Rieder, P Schestatsky, MP Socal, TL Monte, D Fricke, J Costa, ... Clinical neuropharmacology 30 (1), 39-42, 2007 | 79 | 2007 |
| Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives CR Cecchin, AP Pires, CR Rieder, TL Monte, I Silveira, T Carvalho, ... Public Health Genomics 10 (1), 19-26, 2006 | 74 | 2006 |
| Quality of life in a Brazilian sample of patients with Parkinson's disease and their caregivers P Schestatsky, VC Zanatto, R Margis, E Chachamovich, M Reche, ... Brazilian Journal of Psychiatry 28, 209-211, 2006 | 73 | 2006 |
| Hyperhidrosis in Parkinson's disease P Schestatsky, J Valls‐Solé, JA Ehlers, CRM Rieder, I Gomes Movement disorders 21 (10), 1744-1748, 2006 | 70 | 2006 |
| Evaluation of sympathetic skin response in Parkinson's disease P Schestatsky, JA Ehlers, CRM Rieder, I Gomes Parkinsonism & related disorders 12 (8), 486-491, 2006 | 66 | 2006 |
| Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions MP Socal, VE Emmel, CRM Rieder, A Hilbig, ML Saraiva-Pereira, ... Parkinsonism & related disorders 15 (5), 374-378, 2009 | 65 | 2009 |
| The impact of dysphagia therapy on quality of life in patients with Parkinson's disease as measured by the swallowing quality of life questionnaire (SWALQOL) A Ayres, GP Jotz, CRM Rieder, AFS Schuh, MR Olchik International archives of otorhinolaryngology 20, 202-206, 2016 | 64 | 2016 |
| Cytochrome P450 1B1 mRNA in the human central nervous system. CR Rieder, DB Ramsden, AC Williams Molecular Pathology 51 (3), 138, 1998 | 62 | 1998 |
